{
 "company": "pear-therapeutics",
 "as_of": "2026-10-09",
 "choices": [
  {
   "id": "pear-therapeutics-p01",
   "business": "Prescription digital therapeutics",
   "category": "product",
   "dimension": "Treatment portfolio",
   "statement": "Three prescription digital treatments addressed distinct diagnosed conditions.",
   "event_date": "2022-12-31",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "PE1"
   ]
  },
  {
   "id": "pear-therapeutics-p02",
   "business": "Prescription digital therapeutics",
   "category": "product",
   "dimension": "Clinician workflow",
   "statement": "Pear offered a clinician dashboard alongside patient treatment.",
   "event_date": "2022-12-31",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "PE1"
   ]
  },
  {
   "id": "pear-therapeutics-p03",
   "business": "Prescription digital therapeutics",
   "category": "product",
   "dimension": "Fulfillment",
   "statement": "Reported fulfillment was 53% of prescriptions.",
   "event_date": "2022-12-31",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "PE1"
   ]
  },
  {
   "id": "pear-therapeutics-g01",
   "business": "Prescription digital therapeutics",
   "category": "go_to_market",
   "dimension": "Payer access",
   "statement": "Pear pursued payer, provider and government access agreements.",
   "event_date": "2022-12-31",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "PE1"
   ]
  },
  {
   "id": "pear-therapeutics-g02",
   "business": "Prescription digital therapeutics",
   "category": "go_to_market",
   "dimension": "Paid conversion",
   "statement": "Payment covered 41% of fulfilled prescriptions in 2022.",
   "event_date": "2022-12-31",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "PE1"
   ]
  },
  {
   "id": "pear-therapeutics-g03",
   "business": "Prescription digital therapeutics",
   "category": "go_to_market",
   "dimension": "Bankruptcy",
   "statement": "Chapter 11 filing accompanied workforce reductions and a proposed sale process.",
   "event_date": "2023-04-07",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "PE2"
   ]
  }
 ]
}